Lipid Metabolism Practice Questions

Q: Which oil contains the maximum proportion of unsaturated fatty acids?

Safflower oil. ### Educational Explanation The degree of unsaturation in dietary fats is determined by the number of double bonds in their fatty acid chains. High intake of **Polyunsaturated Fatty Acids (PUFA)** is clinically significant as they help lower LDL cholesterol and reduce the risk of cardiovascular diseases. **Why Safflower Oil is Correct:** Safflower oil contains the highest concentration of unsaturated fatty acids (approximately **85–90%**), specifically **Linoleic acid** (an omega-6 PUFA). In medical biochemistry, it is often cited as the gold standard for high PUFA content, making it a preferred dietary recommendation for patients with hyperlipidemia. **Analysis of Incorrect Options:** * **Mustard Oil:** While it contains high levels of monounsaturated fatty acids (MUFA) like Oleic acid and Erucic acid, its total PUFA content is significantly lower than that of safflower oil. * **Groundnut (Peanut) Oil:** This is primarily a MUFA-rich oil (about 50% Oleic acid). While healthier than saturated fats, its total unsaturation level does not match safflower or sunflower oils. * **Coconut Oil:** This is a **saturated fat** (approx. 90% saturated). It is unique because it is rich in Medium-Chain Triglycerides (MCTs) like Lauric acid, but it has the *least* proportion of unsaturated fatty acids among the options. **High-Yield Clinical Pearls for NEET-PG:** * **P/S Ratio:** The ratio of Polyunsaturated to Saturated fatty acids. Safflower oil has one of the highest P/S ratios (~10:1). * **Essential Fatty Acids (EFA):** Linoleic acid (ω-6) and Linolenic acid (ω-3) cannot be synthesized by the body and must be obtained from oils like safflower and sunflower. * **Order of PUFA content:** Safflower > Sunflower > Corn > Soyabean > Groundnut. * **Coconut Oil Exception:** Despite being a plant oil, it is solid at room temperature due to its high saturated fat content, unlike most other vegetable oils.

Q: Niemann-Pick disease is due to deficiency of which enzyme?

Sphingomyelinase. **Explanation:** Niemann-Pick disease (specifically Types A and B) is a lysosomal storage disorder characterized by the deficiency of the enzyme **Acid Sphingomyelinase**. **1. Why Sphingomyelinase is correct:** Acid sphingomyelinase is responsible for the hydrolysis of **sphingomyelin** into ceramide and phosphorylcholine. When this enzyme is deficient, sphingomyelin accumulates within the lysosomes of macrophages (forming characteristic "foam cells") in various organs, primarily the liver, spleen, and brain. This leads to hepatosplenomegaly and progressive neurodegeneration. **2. Why the other options are incorrect:** * **Ceramidase:** Deficiency leads to **Farber disease**, characterized by painful joint swelling, hoarseness (laryngeal nodules), and subcutaneous nodules. * **Galactosidase:** Deficiency of $\beta$-Galactosidase leads to **GM1 Gangliosidosis** or **Krabbé disease** (specifically Galactosylceramidase), while $\alpha$-Galactosidase A deficiency causes **Fabry disease**. * **Glucosidase:** Deficiency of $\beta$-Glucosidase (Glucocerebrosidase) leads to **Gaucher disease**, the most common lysosomal storage disorder. **3. High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Autosomal Recessive. * **Pathognomonic Feature:** **"Foam cells"** (lipid-laden macrophages with a "mulberry" or "soap bubble" appearance) in the bone marrow. * **Clinical Triad:** Hepatosplenomegaly, progressive neurodegeneration, and a **Cherry-red spot** on the macula (also seen in Tay-Sachs, but Tay-Sachs lacks hepatosplenomegaly). * **Niemann-Pick Type C:** Unlike A and B, Type C is due to a defect in **cholesterol transport** (NPC1 or NPC2 genes), not a primary sphingomyelinase deficiency.

Q: Acetyl-CoA is transported out of the mitochondria to serve as a substrate for fatty acid or cholesterol synthesis. Which of the following enzymes involved in this transport process provides NADPH required for these reductive biosynthesis reactions?

Malic enzyme. **Explanation:** Fatty acid synthesis occurs in the cytosol, but Acetyl-CoA is produced in the mitochondria. Since the inner mitochondrial membrane is impermeable to Acetyl-CoA, it condenses with oxaloacetate to form **Citrate**, which is transported out via the tricarboxylate transporter (the **Citrate Shuttle**). **Why Malic Enzyme is correct:** Once in the cytosol, citrate is cleaved back into Acetyl-CoA and oxaloacetate. The oxaloacetate is reduced to malate, which is then decarboxylated by **Malic Enzyme** to form pyruvate. This specific reaction reduces NADP+ to **NADPH**. This is a high-yield concept because NADPH is the essential reducing equivalent required for the reductive biosynthesis of fatty acids and cholesterol. **Analysis of Incorrect Options:** * **A. ATP-citrate lyase:** This enzyme cleaves Citrate into Acetyl-CoA and Oxaloacetate in the cytosol. While it is essential for the shuttle, it does not produce NADPH. * **B. Citrate synthase:** This is a mitochondrial enzyme that condenses Acetyl-CoA and Oxaloacetate to form Citrate. It is the first step of the TCA cycle and the shuttle, but it does not generate reducing power. * **C. Malate dehydrogenase:** The cytosolic version of this enzyme converts oxaloacetate to malate using NADH. It actually *consumes* reducing equivalents rather than producing NADPH. **High-Yield NEET-PG Pearls:** * **Sources of NADPH:** The two primary sources for fatty acid synthesis are the **Pentose Phosphate Pathway (HMP Shunt)** (major source) and the **Malic Enzyme** reaction (minor but significant source). * **Rate-limiting step:** The rate-limiting enzyme for fatty acid synthesis is **Acetyl-CoA Carboxylase (ACC)**, which requires Biotin. * **Location:** Remember "Link reaction/TCA = Mitochondria" vs. "Fatty acid synthesis = Cytosol." The Citrate Shuttle bridges this gap.

Q: Refsum's disease is due to the accumulation of which substance?

Phytanic acid. **Explanation:** **Refsum’s disease** (Hereditary Motor and Sensory Neuropathy Type IV) is a rare autosomal recessive peroxisomal disorder. It is caused by a deficiency in the enzyme **Phytanoyl-CoA hydroxylase**, which is essential for **Alpha-oxidation**. 1. **Why Phytanic acid is correct:** Phytanic acid is a branched-chain fatty acid derived from chlorophyll in the diet (found in dairy and ruminant fats). Because it has a methyl group at the beta-carbon, it cannot undergo standard Beta-oxidation. It must first undergo Alpha-oxidation to remove one carbon atom. In Refsum’s disease, this pathway is blocked, leading to the toxic accumulation of **Phytanic acid** in tissues and plasma. 2. **Why other options are incorrect:** * **C26-C38 polyenoic acids:** These are very-long-chain fatty acids (VLCFA) associated with **Zellweger Syndrome**, where peroxisome biogenesis is defective. * **C6-C10 dicarboxylic acids:** These are typically seen in **MCAD deficiency** (Medium-chain acyl-CoA dehydrogenase deficiency) due to increased omega-oxidation when beta-oxidation fails. * **Palmitic acid:** This is a common 16-carbon saturated fatty acid that undergoes normal beta-oxidation; its accumulation is not characteristic of Refsum’s disease. **Clinical Pearls for NEET-PG:** * **Classic Tetrad:** Retinitis pigmentosa (earliest sign), peripheral neuropathy, cerebellar ataxia, and sensorineural hearing loss. * **Ichthyosis:** Skin changes are a common diagnostic clue. * **Treatment:** Strict dietary restriction of chlorophyll-containing foods (green leafy vegetables) and ruminant fats/dairy. Plasmapheresis may be used in acute cases. * **Key Enzyme:** Phytanoyl-CoA hydroxylase (Alpha-oxidation).

Q: The elongation of fatty acids occurs in which of the diagrammatic structures shown in the illustration?

Structure C. ***Structure C*** - Represents the **smooth endoplasmic reticulum (SER)**, which is the primary site of **fatty acid elongation** using **elongase enzymes** and **malonyl-CoA**. - The **ER elongation system** extends fatty acids beyond C16, particularly producing **long-chain fatty acids** essential for membrane synthesis. *Structure A* - Likely represents the **cytoplasm/cytosol**, where **de novo fatty acid synthesis** occurs via **fatty acid synthase**, but not elongation. - This compartment produces **palmitic acid (C16)** as the primary product, requiring further elongation elsewhere. *Structure B* - Appears to represent **mitochondria**, primarily involved in **beta-oxidation** for fatty acid breakdown, not elongation. - While minor elongation can occur here, it's not the main site and involves different enzyme systems. *Structure D* - Likely represents **peroxisomes**, which handle **very long-chain fatty acid oxidation** and some elongation of specific fatty acids. - These organelles are specialized for **branched-chain fatty acids** and detoxification, not general fatty acid elongation.

Q: Which of the following is not an essential unsaturated fatty acid?

Palmitoleic acid. ### Explanation **Correct Answer: D. Palmitoleic acid** **1. Why Palmitoleic acid is the correct answer:** Essential fatty acids (EFAs) are those that the human body cannot synthesize de novo because humans lack the enzymes (**$\Delta^{12}$ and $\Delta^{15}$ desaturases**) required to introduce double bonds beyond the $\Delta^9$ position. **Palmitoleic acid** is an omega-7 monounsaturated fatty acid (16:1; $\Delta^9$). Since the double bond is at the 9th carbon, the human body can synthesize it from palmitic acid using the $\Delta^9$ desaturase enzyme. Therefore, it is **non-essential**. **2. Analysis of Incorrect Options:** * **Linoleic acid (18:2; $\Delta^{9,12}$):** An Omega-6 fatty acid. It is strictly essential because the double bond at $\Delta^{12}$ cannot be created by human enzymes. It serves as the precursor for Arachidonic acid. * **Linolenic acid (18:3; $\Delta^{9,12,15}$):** An Omega-3 fatty acid. It is strictly essential due to the double bonds at $\Delta^{12}$ and $\Delta^{15}$. * **Arachidonic acid (20:4; $\Delta^{5,8,11,14}$):** An Omega-6 fatty acid. It is considered **conditionally essential**. It can be synthesized from Linoleic acid; however, if Linoleic acid is deficient in the diet, Arachidonic acid becomes essential. In the context of NEET-PG, it is traditionally grouped with essential fatty acids. **3. High-Yield Clinical Pearls for NEET-PG:** * **True Essential Fatty Acids:** Only Linoleic and $\alpha$-Linolenic acid are "true" EFAs. * **EFA Deficiency:** Characterized by **Phrynoderma** (follicular hyperkeratosis/toad skin), scaly dermatitis, and poor wound healing. * **Precursor Role:** Arachidonic acid is the immediate precursor for **prostaglandins, leukotrienes, and thromboxanes** (Eicosanoids). * **Omega Nomenclature:** Count from the methyl ($\omega$) end; $\Delta$ nomenclature counts from the carboxyl (COOH) end.

Q: Lithogenic bile has which of the following properties?

Decreased bile and cholesterol ratio. **Explanation:** The formation of gallstones (cholelithiasis) is primarily driven by the production of **lithogenic bile**. Bile is a complex fluid containing bile salts, phospholipids (lecithin), and cholesterol. Under normal physiological conditions, cholesterol—which is water-insoluble—is kept in a soluble state by being incorporated into mixed micelles formed by bile salts and phospholipids. **1. Why Option B is Correct:** Bile becomes lithogenic when it is **supersaturated with cholesterol**. This occurs due to either an absolute increase in cholesterol secretion or a relative decrease in bile salts and phospholipids. Therefore, a **decreased bile salt-to-cholesterol ratio** means there is insufficient "detergent" (bile salts) to keep the cholesterol in solution. This leads to the precipitation of cholesterol crystals, which eventually aggregate to form stones. **2. Why Incorrect Options are Wrong:** * **Option A:** An increased bile-to-cholesterol ratio would mean more bile salts are available to solubilize cholesterol, making the bile *less* likely to form stones (non-lithogenic). * **Option C:** An equal ratio does not account for the specific saturation index required to maintain solubility; supersaturation is the key driver. * **Option D:** Decreased cholesterol would actually decrease the risk of stone formation, as the bile would be undersaturated. **NEET-PG High-Yield Pearls:** * **The Solubility Triangle:** The stability of bile depends on the molar ratios of bile salts, lecithin, and cholesterol (Admirand-Small Triangle). * **Rate-Limiting Enzyme:** **7-alpha-hydroxylase** is the rate-limiting enzyme for bile acid synthesis. Its deficiency or inhibition leads to lithogenic bile. * **Risk Factors (The 4 F's):** Fat, Female, Fertile, and Forty. * **Statin Mechanism:** HMG-CoA reductase inhibitors (Statins) can reduce the lithogenicity of bile by decreasing biliary cholesterol secretion.

Q: Which protein, having structural homology with plasminogen, is responsible for myocardial infarction and stroke?

LP(a). **Explanation:** **Lipoprotein(a) [Lp(a)]** is the correct answer because it consists of an LDL-like particle containing **Apolipoprotein B-100** linked to a unique glycoprotein called **Apolipoprotein(a)**. 1. **Mechanism of Action:** Apo(a) shares significant **structural homology with Plasminogen**, the precursor to plasmin. Due to this similarity, Lp(a) competitively inhibits the binding of plasminogen to fibrin and endothelial cell receptors. This impairs fibrinolysis (clot breakdown) and promotes thrombosis. Furthermore, Lp(a) is highly pro-atherogenic as it deposits cholesterol into the arterial wall. This dual **pro-thrombotic and pro-atherogenic** nature significantly increases the risk of Myocardial Infarction (MI) and Stroke. **Analysis of Incorrect Options:** * **A. HDL:** Known as "good cholesterol," it mediates reverse cholesterol transport. High levels are cardioprotective, not causative of MI. * **C. LDL:** While the primary carrier of cholesterol and a major risk factor for atherosclerosis, it lacks the plasminogen-like Apo(a) component. * **D. Homocysteine:** High levels (Hyperhomocysteinemia) are a risk factor for vascular disease due to endothelial damage, but it is an amino acid derivative, not a protein with structural homology to plasminogen. **High-Yield Facts for NEET-PG:** * **Kringles:** The structural homology between Apo(a) and plasminogen lies in the **"Kringle IV"** repeats. * **Genetic Determinant:** Lp(a) levels are primarily genetically determined and are not significantly altered by diet or statins. * **Niacin:** Historically, Niacin was used to lower Lp(a), though its clinical benefit on outcomes remains debated. * **Clinical Marker:** Lp(a) is considered an independent risk factor for premature coronary artery disease (CAD).

Question 1

Which oil contains the maximum proportion of unsaturated fatty acids?

Accepted Answer

Safflower oil

Answer

Mustard oil

Answer

Groundnut oil

Answer

Coconut oil

Question 2

Niemann-Pick disease is due to deficiency of which enzyme?

Accepted Answer

Sphingomyelinase

Answer

Ceramidase

Answer

Galactosidase

Answer

Glucosidase

Question 3

Acetyl-CoA is transported out of the mitochondria to serve as a substrate for fatty acid or cholesterol synthesis. Which of the following enzymes involved in this transport process provides NADPH required for these reductive biosynthesis reactions?

Accepted Answer

Malic enzyme

Answer

ATP-citrate lyase

Answer

Citrate synthase

Answer

Malate dehydrogenase

Question 4

What is the best marker for the prediction of coronary artery disease?

Accepted Answer

LDL/HDL ratio

Answer

Serum cholesterol

Answer

Cholesterol/Triglyceride ratio

Answer

Blood cholesterol

Question 5

Refsum's disease is due to the accumulation of which substance?

Accepted Answer

Phytanic acid

Answer

C26-C38 polyenoic acids

Answer

C6-C10 o-dicarboxylic acids

Answer

Palmitic acid

Question 6

Which one of the following is a precursor of both gonadal and adrenocortical hormones?

Accepted Answer

Progesterone

Answer

Cortisol

Answer

Testosterone

Answer

Corticosterone

Question 7

The elongation of fatty acids occurs in which of the diagrammatic structures shown in the illustration?

Accepted Answer

Structure C

Answer

Structure A

Answer

Structure B

Answer

Structure D

Question 8

Which of the following is not an essential unsaturated fatty acid?

Accepted Answer

Palmitoleic acid

Answer

Linoleic acid

Answer

Linolenic acid

Answer

Arachidonic acid

Question 9

Lithogenic bile has which of the following properties?

Accepted Answer

Decreased bile and cholesterol ratio

Answer

Increased bile and cholesterol ratio

Answer

Equal bile and cholesterol ratio

Answer

Decreased cholesterol only

Question 10

Which protein, having structural homology with plasminogen, is responsible for myocardial infarction and stroke?

Accepted Answer

LP(a)

Answer

HDL

Answer

LDL

Answer

Homocysteine

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?